Source: Medicines & Healthcare Products Regulatory Agency (GB) Revision Year: 2024 Publisher: AstraZeneca UK Limited, 1 Francis Crick Avenue, Cambridge, CB2 0AA, UK
Nexium I.V. 40 mg Powder for solution for injection/infusion.
| Pharmaceutical Form |
|---|
|
Powder for solution for injection/infusion. White to off-white porous cake or powder. |
Each vial contains esomeprazole 40 mg (as sodium salt).
Excipient(s) with known effect:
This medicinal product contains <1 mmol sodium (23 mg) per 40 mg, i.e. essentially sodium free.
For the full list of excipients, see section 6.1.
| Active Ingredient |
|---|
|
Esomeprazole is a weak base and is concentrated and converted to the active form in the highly acidic environment of the secretory canaliculi of the parietal cell, where it inhibits the enzyme H+K+-ATPase – the acid pump and inhibits both basal and stimulated acid secretion. |
| List of Excipients |
|---|
|
Disodium edetate |
5 ml vial made of colourless borosilicate glass, type I. Stopper made of bromobutyl latex-free rubber, cap made of aluminium and a plastic flip-off seal.
Pack sizes: 1 vial, 10 vials.
Not all pack sizes may be marketed.
AstraZeneca UK Limited, 1 Francis Crick Avenue, Cambridge, CB2 0AA, UK
PL 17901/0221
Date of first authorisation: 10 March 2005
Date of latest renewal: 10 March 2010
| Drug | Countries | |
|---|---|---|
| NEXIUM | Austria, Australia, Brazil, Canada, Cyprus, Germany, Ecuador, Estonia, Spain, Finland, France, Hong Kong, Croatia, Ireland, Israel, Italy, Japan, Lithuania, Malta, Mexico, Nigeria, Netherlands, New Zealand, Poland, Romania, Singapore, Tunisia, Turkey, United Kingdom, United States |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.